Literature DB >> 24206098

Buspirone use in the treatment of atomoxetine-induced bruxism.

Murat Yüce1, Koray Karabekiroğlu, Gökçe Nur Say, Mahmut Müjdeci, Meral Oran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24206098      PMCID： PMC3842865          DOI： 10.1089/cap.2013.0087

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


× No keyword cloud information.
  15 in total

1.  Citalopram-induced bruxism.

Authors:  M Wise
Journal:  Br J Psychiatry       Date:  2001-02       Impact factor: 9.319

2.  Buspirone as an antidote to venlafaxine-induced bruxism.

Authors:  M S Jaffee; J M Bostwick
Journal:  Psychosomatics       Date:  2000 Nov-Dec       Impact factor: 2.386

3.  Drugs and bruxism: a critical review.

Authors:  Ephraim Winocur; Anat Gavish; Michal Voikovitch; Alona Emodi-Perlman; Ilana Eli
Journal:  J Orofac Pain       Date:  2003

4.  Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

Authors:  David Michelson; Albert J Allen; Joan Busner; Charles Casat; David Dunn; Christopher Kratochvil; Jeffrey Newcorn; F Randy Sallee; R Bart Sangal; Keith Saylor; Scott West; Douglas Kelsey; Joachim Wernicke; Nancy J Trapp; Donald Harder
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

Review 5.  Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations.

Authors:  Mark L Wolraich; Laura McGuinn; Melissa Doffing
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Buspirone as an antidote to SSRI-induced bruxism in 4 cases.

Authors:  J M Bostwick; M S Jaffee
Journal:  J Clin Psychiatry       Date:  1999-12       Impact factor: 4.384

7.  Sleep bruxism; an overview of an oromandibular sleep movement disorder. REVIEW ARTICLE.

Authors:  Gaby Bader; Gilles Lavigne
Journal:  Sleep Med Rev       Date:  2000-02       Impact factor: 11.609

8.  Bruxism secondary to chronic antidopaminergic drug exposure.

Authors:  F Micheli; M Fernandez Pardal; M Gatto; J Asconapé; R Giannaula; I C Parera
Journal:  Clin Neuropharmacol       Date:  1993-08       Impact factor: 1.592

Review 9.  The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.

Authors:  Andrew S Rowland; Catherine A Lesesne; Ann J Abramowitz
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

10.  Worsening of bruxism with atomoxetine: a case report.

Authors:  Dattatreya Mendhekar; Deep Lohia
Journal:  World J Biol Psychiatry       Date:  2009       Impact factor: 4.132
View more
  1 in total

Review 1.  SSRI-associated bruxism: A systematic review of published case reports.

Authors:  Andrew R Garrett; Jason S Hawley
Journal:  Neurol Clin Pract       Date:  2018-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.